Multiple sclerosis patients have a diminished serologic response to vitamin D supplementation compared to healthy controls

Plasma Levels of 25-Hydroxyvitamin D3andIn VivoMarkers of Cytochrome P450 3A Activity in Swedes and Koreans: Effects of a Genetic Polymorphism and Oral Contraceptives

(2014) Hanna Nylén et al.   BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY

The Vitamin D to Ameliorate Multiple Sclerosis (VIDAMS) trial: Study design for a multicenter, randomized, double-blind controlled trial of vitamin D in multiple sclerosis

(2014) Pavan Bhargava et al.   Contemporary Clinical Trials

Intestinal transport and metabolism of bile acids

(2014) Paul A. Dawson et al.   JOURNAL OF LIPID RESEARCH

A Predictive Equation to Guide Vitamin D Replacement Dose in Patients

(2014) G. Singh et al.   Journal of the American Board of Family Medicine

Predictors of serum 25(Oh)D increase following bimonthly supplementation with 100,000IU vitamin D in healthy, men aged 25–65 years

(2013) Sigal Tepper et al.   JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY

Association between bile acid turnover and osteoporosis in postmenopausal women

(2013) Ruth Hanly et al.   NUCLEAR MEDICINE COMMUNICATIONS

Increased Plasma Concentrations of Vitamin D Metabolites and Vitamin D Binding Protein in Women Using Hormonal Contraceptives: A Cross-Sectional Study

(2013) Ulla Møller et al.   Nutrients

No evidence of association between mutant alleles of theCYP27B1gene and multiple sclerosis

(2012) Maria Ban et al.   ANNALS OF NEUROLOGY

Interferon-  and serum 25-hydroxyvitamin D interact to modulate relapse risk in MS

(2012) N. Stewart et al.   NEUROLOGY

Efficacy of Vitamin D Supplementation in Multiple Sclerosis (EVIDIMS Trial): study protocol for a randomized controlled trial

(2012) Jan Dörr et al.   Trials

Rare variants in the CYP27B1 gene are associated with multiple sclerosis

(2011) Sreeram V. Ramagopalan et al.   ANNALS OF NEUROLOGY

Vitamin D3: a helpful immuno-modulator

(2011) Michelino Di Rosa et al.   IMMUNOLOGY

Efficacy of vitamin D3 as add-on therapy in patients with relapsing–remitting multiple sclerosis receiving subcutaneous interferon beta-1a: A Phase II, multicenter, double-blind, randomized, placebo-controlled trial

(2011) Joost Smolders et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

1,25-Dihydroxyvitamin D3 Ameliorates Th17 Autoimmunity via Transcriptional Modulation of Interleukin-17A

(2011) S. Joshi et al.   MOLECULAR AND CELLULAR BIOLOGY

Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

(2011) Stephen Sawcer et al.   NATURE

Serum 25-hydroxyvitamin D status of vegetarians, partial vegetarians, and nonvegetarians: the Adventist Health Study-2

(2009) Jacqueline Chan et al.   AMERICAN JOURNAL OF CLINICAL NUTRITION

Vitamin D status and effect of low-dose cholecalciferol and high-dose ergocalciferol supplementation in multiple sclerosis

(2009) GS Hiremath et al.   Multiple Sclerosis Journal

Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20

(2009) Melanie Bahlo et al.   NATURE GENETICS